Inventure Grow. (INVENTURE)
TurnaroundScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹0.92 |
| Market Cap | ₹96.6 Cr |
| P/E Ratio | 30.67 |
| ROCE | 3.48% |
| ROE | 3.3% |
| Dividend Yield | 0% |
| Profit Growth | -13.7% |
| Debt/Equity | 0.13 |
| Sales Growth | -9.8% |
| Promoter Holding | 26.4% |
| 52-Week Range | ₹0.81 — ₹1.68 |
| Sector | Capital Markets |
| Book Value | ₹2.64 |
Strengths
- Trading below book value with P/B of 0.72 against book value of ₹1.40, offering asset-based margin of safety.
- Low leverage with Debt/Equity of 0.10, limiting financial distress risk.
- Piotroski F-Score of 7/9 suggests improving financial fundamentals.
- Reported sales growth of 40.93% and latest quarter net profit of ₹3 Cr show recent operating momentum.
- P/E of 15.86 is not excessive if the profit recovery sustains.
Concerns
- Weak profitability with ROE of only 3.30% and ROCE of 3.48% reflects poor capital efficiency.
- Stockbroking is commoditised and cyclical with no durable competitive moat.
- Low promoter holding of 26.40% raises governance and alignment concerns.
- Zero dividend means total return depends entirely on capital appreciation, adding speculative risk.
AI Analysis
At ₹1.01, Inventure Grow is not a wonderful business; a wonderful business would earn far more than 3.30% ROE. This is a small stockbroking and allied services company with a market cap of ₹113 Cr, trading at 0.72 times book value while book value stands at ₹1.40. Graham would be drawn to the asset backing, but he would also insist that the balance sheet not be a trap. Debt/equity is only 0.10, so financial risk is limited. The latest quarter shows sales of ₹16 Cr and net profit of ₹3 Cr. That suggests momentum, but stockbroking is dependent on market volumes; quoted profit growth of 1000% is a low-base effect, not evidence of durable compounding. The Piotroski score of 7/9 is encouraging and tells me fundamentals are improving. Still, 26.40% promoter holding is thin, and no dividend means my return depends on someone paying a higher price later. At P/E 15.86 and a PEG of 0.03, the market expects continued rapid earnings growth. If the company earns like last quarter for several quarters, the equity will look cheap; if the broking cycle turns, a 0.72 P/B may not protect me. ROCE of 3.48% also confirms that capital is not yet being used efficiently. I would treat this as a small turnaround observation, not a core compounder. I need several consecutive quarters of profitable growth and higher ROE before trusting the recovery. Until then, the margin of safety is in the asset value, not in the franchise.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer